Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
17.71
+0.46 (2.67%)
Nov 5, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 3.55 billion as of November 5, 2026. It is the 14,025th most valuable company in the world and the 3,701st biggest in China. Its market cap has decreased by 18.48% in one year.
Market Cap
3.55B
Enterprise Value
3.60B
Revenue
1.71B
Global Rank
Country Rank
#3,701 China
PE Ratio
11.39
ChartMarket Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 3.55B, a decrease of -48.07%. That is a compound annual growth rate of -10.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 3.55B | -15.06% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 3.76B |
| Beijing Bohui Innovation Biotechnology Group | 3.69B |
| Assure Tech (Hangzhou) | 3.50B |
| Beijing Scitop Bio-tech | 3.46B |
| Shanghai Serum Bio-Technology | 3.38B |
| Hefei Lifeon Pharmaceutical | 3.37B |
| Shanghai Model Organisms Center | 3.27B |
| Baolingbao Biology | 3.22B |